Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2

Interventions

Specimen Handling 456Magnetic Resonance Spectroscopy 347pembrolizumab 287Biopsy 245Carboplatin 228Cisplatin 194Cyclophosphamide 178Paclitaxel 160Nivolumab 153Gemcitabine 147Bevacizumab 126Radiotherapy 124Dexamethasone 110Pemetrexed 101fludarabine 96Fluorouracil 95atezolizumab 93Radiation 92Docetaxel 90venetoclax 89Doxorubicin 88durvalumab 85Oxaliplatin 85Rituximab 84Leucovorin 81Capecitabine 76Prednisone 73Lenalidomide 70X-Rays 69Etoposide 67

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
saponin QA-21V1 × 30 days × Clear all
NCT06057948 2026-06-05

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
94 enrolled
CNS

Neuroblastoma

NCT04936529 2026-05-07

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
286 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡